Form 4: Globus Medical Director Leslie V. Norwalk Sells Shares Under 10b5-1 Trading Plan

Director Leslie V. Norwalk sold 10,590 shares of Globus Medical Inc. (GMED) at an average price of $51.99 on March 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 15, 2024, Leslie V. Norwalk, a director of Globus Medical Inc. (GMED), sold 10,590 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $51.99 per share.
• The transactions occurred within a price range of $51.90 to $52.25.
• The sale was conducted under a Rule 10b5-1 trading plan established on December 14, 2023.
• Following the transaction, Norwalk directly owns 17,419 shares of Globus Medical Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be part of a pre-planned trading strategy and doesn't inherently indicate a positive or negative outlook on the company.

Industry Context

Sales by company directors are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance. Investors often monitor these transactions for significant patterns or unusual activity.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder confidence, but the existence of a 10b5-1 trading plan mitigates this concern.

Key Dates